prenylamine has been researched along with cardiovascular agents in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (90.91) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grosse, G; Lindner, G; Plonka, G | 1 |
| Fromm, BS; Lehmann, MH; Makkar, RR; Meissner, MD; Steinman, RT | 1 |
| BAUMGARTEN, A | 1 |
| DELLA PORTA, P; LUCCHELLI, PD; LUCCHINI, CR | 1 |
| MATANO, F; ROMANO, V | 1 |
| ANFOSSI, F; ANSELMINO, A; BERT, G; BIANCO, A; MIGHELI, B; PUPITA, F | 1 |
| WALTHER, H | 1 |
| KOHLER, H | 1 |
| LUISADA, AA; NEUMANN, M | 1 |
| KNABE, J | 1 |
| KERRIDGE, DF; MAZURKIE, SJ; VEREL, D | 1 |
2 review(s) available for prenylamine and cardiovascular agents
| Article | Year |
|---|---|
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramide; Female; Humans; Male; Middle Aged; Prenylamine; Procainamide; Quinidine; Risk Factors; Sex; Sotalol; Syncope; Tachycardia, Ventricular; Torsades de Pointes | 1993 |
[CHEMISTRY OF CARDIAC DRUGS].
Topics: Alkaloids; Anti-Arrhythmia Agents; Cardiovascular Agents; Coumarins; Digitalis Glycosides; Dipyridamole; Humans; Nitrates; Nitrites; Phenols; Prenylamine; Procainamide; Quinidine; Rauwolfia; Vasodilator Agents | 1964 |
9 other study(ies) available for prenylamine and cardiovascular agents
| Article | Year |
|---|---|
[The effects of certain psycho- and coronary therapeutic agents on nerve tissue in vitro].
Topics: Animals; Cardiovascular Agents; Cells, Cultured; Dipyridamole; Ganglia; Hippocampus; Meclofenamic Acid; Nerve Tissue; Piracetam; Prenylamine; Psychotropic Drugs; Rats | 1978 |
The clinical effects of a new anti-anginal agent, prenylamine ("Segontin").
Topics: Angina Pectoris; Cardiovascular Agents; Prenylamine; Vasodilator Agents | 1962 |
[Clinical considerations on the therapeutic action of a new drug with anti-angina action (FPDFPA)].
Topics: Cardiovascular Agents; Coronary Disease; Humans; Prenylamine | 1963 |
[Observations on the subject of clinical experimentation of a new synthetic antianginal compound: N-3'-phenyl-propyl-(2')-1,1-diphenyl-propyl-(3)-amine].
Topics: Amines; Biphenyl Compounds; Cardiovascular Agents; Humans; Prenylamine; Research Design | 1963 |
[Experimental and clinical observations on the action of a new anti-angina drug: 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine lactate or FPDFPA].
Topics: Biphenyl Compounds; Cardiovascular Agents; Coronary Disease; Humans; Lactates; Lactic Acid; Prenylamine; Propylamines | 1963 |
[Clinical experiences with the coronary drug SA30].
Topics: Cardiovascular Agents; Coronary Disease; Prenylamine | 1963 |
Recently introduced cardiovascular drugs under experimental test.
Topics: Cardiovascular Agents; Coronary Vessels; Dipyridamole; Humans; Prenylamine; Vasodilator Agents | 1963 |
EFFECT OF RAPID AND SLOW-ACTING "CORONARY" DRUGS ON PRECORDIAL PAIN OF THE AGED.
Topics: Angina Pectoris; Cardiovascular Agents; Chest Pain; Chlordiazepoxide; Dipyridamole; Electrocardiography; Geriatrics; Humans; Pentaerythritol Tetranitrate; Prenylamine | 1964 |
A clinical trial of prenylamine lactate--a long-lasting coronary dilator drug.
Topics: Angina Pectoris; Cardiovascular Agents; Lactates; Prenylamine; Vasodilator Agents | 1961 |